In April 2025, the National Security Commission on Emerging Biotechnology (NSCEB) released its final report, Charting the Future of Biotechnology: An action plan for American security and prosperity. This bipartisan commission, established by Congress, was tasked with assessing how biotechnology will shape America’s national security, economy, and global standing in the decades ahead.
Its findings are clear: biotechnology is no longer a niche scientific field—it is a central force in determining whether the United States can remain secure, prosperous, and globally competitive. From the medicines that heal us, to the crops that feed us, to the materials and tools that fuel our economy and defense, biotechnology will define much of the 21st century.
Even more alarmingly, the Commission found that without deliberate investment in biotechnology and coordinated efforts across the federal government, the United States risks falling behind the Chinese Communist Party (CCP) in biotechnological development.
At With Honor Institute, reports like this deserve more than just a headline. They deserve thoughtful, public-facing discussion that connects complex policy to everyday life. Commenting on this report aligns directly with that mission to educate and support principled veterans and servant leaders who bring integrity, civility, and courage into public service. It is a chance to highlight not only what biotechnology means for our future, but also why bipartisan leadership is essential to realizing its promise responsibly.
The NSCEB report warns that America’s leadership in biotechnology is at risk. Other nations, especially China, have accelerated investments while the U.S. risks falling behind. This isn’t just about science—it’s about the very foundation of our economy, security, and credibility in the world.
Three principles stand out:
This is not a partisan issue. It is a defining moment where America must act with unity and urgency.
The report offers a roadmap for action—bold steps that could secure America’s leadership if implemented.
These are not abstract proposals—they are blueprints for jobs, national security, and innovation that touches every American household.
The NSCEB has mapped the path forward. However, the bigger question remains: do we have the leadership to follow it?
Biotechnology is about more than science—it is about values. It will determine how we care for our people, defend our nation, and grow our economy. Seizing this moment requires leaders who embody integrity, civility, and courage.
Billions in biotech funding must be deployed responsibly and transparently, free from political gridlock or short-term interests.
Success will depend on bipartisan cooperation in Congress and collaboration across agencies, industries, and allies.
Leaders must be willing to make bold choices—whether in reforming regulations, funding risky but necessary innovation, or setting ethical boundaries for biotech use.
At With Honor Institute, we know that this kind of principled leadership is not only possible but essential. Supporting veterans and servant leaders in public office is one way to ensure the next generation of decision-makers can rise to challenges like this with clarity and courage.
The NSCEB’s report, Charting the Future of Biotechnology, is a wake-up call. America’s biotech future will not wait. If we act decisively—with bipartisan resolve and principled leadership—we can secure innovation that strengthens our economy, our security, and our democracy.
The choice before us is simple: let biotechnology become another partisan wedge, or use it as a platform to rebuild trust in our institutions and leadership. At our Institute, we know which path we must take.
Biotechnology is no longer niche—it’s central to U.S. security, economy, and global leadership.
The NSCEB recommends bold actions: a White House biotech office, massive R&D investments, modernized regulations, stronger defense safeguards, expanded workforce programs, and international leadership.
America’s ability to act will hinge on principled leadership that prioritizes integrity, civility, and courage over partisanship.
This is a bipartisan opportunity: strengthening biotechnology is not just about science, but about rebuilding trust in our democracy and ensuring America’s future.
